Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
Condition(s):HIV Infections; Acquired Immunodeficiency Syndrome; TuberculosisLast Updated:November 8, 2011Completed
Hide Studies Not Open or Pending
Condition(s):HIV Infections; Acquired Immunodeficiency Syndrome; TuberculosisLast Updated:November 8, 2011Completed
Condition(s):Pulmonary TuberculosisLast Updated:February 28, 2017Completed
Condition(s):TuberculosisLast Updated:January 25, 2022Completed
Condition(s):TuberculosisLast Updated:April 13, 2017Completed
Condition(s):Tuberculosis, Pulmonary; TuberculosisLast Updated:December 8, 2023Completed
Condition(s):Tuberculosis; Human Immunodeficiency Virus InfectionsLast Updated:June 11, 2008Unknown status
Condition(s):Tuberculous MeningitisLast Updated:March 6, 2024Recruiting
Condition(s):Tuberculosis, Multidrug-ResistantLast Updated:February 4, 2019Unknown status
Condition(s):Pulmonary Tuberculosis; Other Specified Pulmonary TuberculosisLast Updated:March 22, 2024Recruiting
Condition(s):Pulmonary TuberculosisLast Updated:January 11, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.